drugset / Trial / NCT00789555

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

NCT00789555

Phase 4 Completed 1260 enrolled Alcon Research
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study was to assess local nasal adverse effects, as well as systemic effects, of PATANASE nasal spray when compared with Patanase Vehicle, pH 3.7 and Patanase Vehicle, pH 7.0 in patients with perennial allergic rhinitis (PAR).

Timeline

Start
2008-11
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified 0.6 % Intranasal